Venlafaxine is a prescription medication classified as a serotonin-norepinephrine reuptake inhibitor. It works by blocking the reabsorption of serotonin and norepinephrine in the brain, thereby increasing the levels of these neurotransmitters. The elevated neurotransmitter concentrations help modulate mood and pain signals, which underlies its therapeutic use in depression and certain anxiety disorders. By enhancing serotonergic and noradrenergic activity, Venlafaxine can reduce persistent feelings of sadness and improve emotional resilience. It also influences descending pain pathways, leading to a diminishment of chronic neuropathic and musculoskeletal pain. The medication acts on central nervous system receptors that regulate both affective and somatic sensations. Through these combined actions, Venlafaxine provides a dual mechanism that addresses both mood disturbances and pain perception. This dual pharmacological profile makes it valuable for patients who experience overlapping mood and pain symptoms.

Venlafaxine is an antidepressant used to treat major depressive disorder and generalized anxiety disorder. It blocks the reuptake of serotonin and norepinephrine in the brain, increasing their levels and enhancing mood regulation. By boosting these neurotransmitters it improves communication between brain cells and lifts depressive symptoms. Its action also stabilizes emotional processing and reduces excessive worry associated with anxiety. As neurotransmitter concentrations rise and neural circuits adapt, its effects develop gradually. It belongs to a class of antidepressants known as serotonin norepinephrine reuptake inhibitors. Overall Venlafaxine provides a targeted pharmacological approach to managing mood and anxiety disorders.

Venlafaxine is a medication that affects the brain's neurotransmitters. It is commonly prescribed to treat depression and certain anxiety conditions. Patients may experience nausea, especially when starting the drug. Headaches and dizziness are also frequently reported. Dry mouth, constipation, and increased sweating can occur during treatment. Some individuals notice changes in sexual desire or performance. Insomnia or sleep disturbances may appear, particularly early in therapy.

Venlafaxine may cause nausea and vomiting in some patients. Headache and dizziness are also frequently reported. Dry mouth and constipation can occur as side effects. Some individuals experience increased sweating or hot flashes. Sleep disturbances such as insomnia or vivid dreams have been noted. Sexual dysfunction including decreased libido or difficulty achieving orgasm is another possible reaction.